Cindy Motz
Stock Analyst at Goldman Sachs
(0.21)
# 3,676
Out of 4,667 analysts
21
Total ratings
17.65%
Success rate
-17.86%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Cindy Motz
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MPLN MultiPlan | Maintains: Neutral | $220 → $82 | $6.45 | +1,171.32% | 2 | Nov 16, 2022 | |
| HQY HealthEquity | Upgrades: Neutral | $64 → $77 | $102.96 | -25.21% | 3 | Oct 21, 2022 | |
| ACCD Accolade | Maintains: Buy | $15 → $16 | $3.56 | +349.44% | 5 | Oct 7, 2022 | |
| HCAT Health Catalyst | Maintains: Buy | $29 → $18 | $7.36 | +144.57% | 5 | Aug 10, 2022 | |
| DOCS Doximity | Maintains: Buy | $53 → $46 | $49.90 | -7.82% | 3 | Aug 8, 2022 | |
| TDOC Teladoc Health | Downgrades: Neutral | $55 → $36 | $9.00 | +300.00% | 3 | Jul 28, 2022 |
MultiPlan
Nov 16, 2022
Maintains: Neutral
Price Target: $220 → $82
Current: $6.45
Upside: +1,171.32%
HealthEquity
Oct 21, 2022
Upgrades: Neutral
Price Target: $64 → $77
Current: $102.96
Upside: -25.21%
Accolade
Oct 7, 2022
Maintains: Buy
Price Target: $15 → $16
Current: $3.56
Upside: +349.44%
Health Catalyst
Aug 10, 2022
Maintains: Buy
Price Target: $29 → $18
Current: $7.36
Upside: +144.57%
Doximity
Aug 8, 2022
Maintains: Buy
Price Target: $53 → $46
Current: $49.90
Upside: -7.82%
Teladoc Health
Jul 28, 2022
Downgrades: Neutral
Price Target: $55 → $36
Current: $9.00
Upside: +300.00%